COVID-19/Coronavirus

Researchers from the Department of Cardiology and Macrovascular Disease, Beijing Tiantan Cardiovascular Hospital in  Beijing, China found that patients with cardiovascular diseases (CVDs) had significantly worse outcomes. They published their findings in a study titled, “An Acute Respiratory Infection Runs Into the Most Common Non-communicable Epidemic— COVID-19 and Cardiovascular Diseases,” in the latest issue of...

In response to the COVID-19 outbreak CMS’ 1135 Waiver calls for the expansion of telehealth services. Medicare can pay for office, hospital, and other visits furnished via telehealth across the country including in patient’s places of residence as of March 6, 2020.  A range of providers, such as doctors, nurse practitioners, clinical psychologists, and licensed clinical...

The U.S. Food and Drug Administration (FDA) recognizes that the need for ventilators, ventilator accessories, and other respiratory devices may outpace the supply available to health care facilities during the Coronavirus Disease 2019 (COVID-19) outbreak. On March 22, 2020, the FDA issued an immediately in effect guidance outlining a policy intended to help increase availability...

The U.S. Food and Drug Administration (FDA) recognizes the need for personal protective equipment (PPE), such as medical gloves, may outpace the supply available to health care organizations during the Coronavirus Disease 2019 (COVID-19) outbreak. This Letter to Health Care Providers refers specifically to potential shortages relating to surgeons’ gloves and patient examination gloves. The...

Physicians on the front line are petitioning for more Personal Protective Equipment during the COVID-19 pandemic. In a Change.org petition with nearly 500,000 signatures Dr. Milla Kviatkovsky proclaims: As cases of COVID-19 escalate around the country, physicians and other healthcare workers (HCWs) are facing severe shortages of personal protective equipment (PPE). This shortage is already...

Study enrolling hospitalized adults with COVID-19 in Nebraska A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed with coronavirus disease 2019 (COVID-19) has begun at the University of Nebraska Medical Center (UNMC) in Omaha. The trial regulatory sponsor is the National Institute of Allergy and...